Tu Xu
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Histone Deacetylase Inhibitors Research 3
- Hematology 10
- Acute Myeloid Leukemia Research 9
- Co-authors
- Andrew H. Wei (7 shared papers)Brenda Chyla (7 shared papers)Jalaja Potluri (5 shared papers)Marina Konopleva (3 shared papers)Anthony Letai (4 shared papers)Daniel A. Pollyea (4 shared papers)Brian A. Jonas (4 shared papers)Keith W. Pratz (4 shared papers)
- Journals
- Blood (7 papers)Journal of Clinical Oncology (5 papers)Annals of the American Thoracic Society (2 papers)Journal of Thoracic Oncology (1 paper)Pharmaceutical Statistics (1 paper)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Tu Xu
26 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Hematology 1.9k
- Genetics 496
- Molecular Biology 1.3k
- Public Health, Environmental and Occupational Health 481
- Oncology 438
Countries citing papers authored by Tu Xu
This map shows the geographic impact of Tu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tu Xu more than expected).
Fields of papers citing papers by Tu Xu
This network shows the impact of papers produced by Tu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tu Xu. The network helps show where Tu Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Tu Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia Hit paper breakdown → | 2018 | 1175 |
| 2 | Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study Hit paper breakdown → | 2018 | 498 |
| 3 | Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study Hit paper breakdown → | 2019 | 456 |
| 4 | 2017 | 49 | |
| 5 | 2015 | 34 | |
| 6 | 2018 | 32 | |
| 7 | 2016 | 30 | |
| 8 | 2014 | 25 | |
| 9 | 2018 | 25 | |
| 10 | 2014 | 23 | |
| 11 | 2014 | 17 | |
| 12 | 2023 | 13 | |
| 13 | 2018 | 8 | |
| 14 | 2024 | 5 | |
| 15 | 2017 | 4 | |
| 16 | 2013 | 4 | |
| 17 | 2017 | 4 | |
| 18 | 2018 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2019 | 2 |
About Tu Xu
Tu Xu is a scholar working on Molecular Biology, Hematology, Oncology, Statistics and Probability and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 2.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Statistical Methods in Clinical Trials (6 papers), Neutropenia and Cancer Infections (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Statistical Methods and Inference (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (496 citations), Molecular Biology (1.3k citations), Public Health, Environmental and Occupational Health (481 citations) and Oncology (438 citations). Tu Xu has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Andrew H. Wei, Brenda Chyla, Jalaja Potluri, Marina Konopleva, Anthony Letai, Daniel A. Pollyea, Brian A. Jonas, Keith W. Pratz, Courtney D. DiNardo and Hagop M. Kantarjian. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of the American Thoracic Society, Journal of Thoracic Oncology and Pharmaceutical Statistics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.